Stockscreener 앱 받기
22.26
0.72%
0.18
전일 마감가:
$22.08
열려 있는:
$22.3
하루 거래량:
1.33M
Relative Volume:
0.25
시가총액:
$11.05B
수익:
$4.45B
순이익/손실:
$205.00M
주가수익비율:
55.65
EPS:
0.4
순현금흐름:
$372.00M
1주 성능:
+4.56%
1개월 성능:
+3.97%
6개월 성능:
+66.84%
1년 성능:
+89.60%
1일 변동 폭
$22.16
$22.69
1주일 범위
$20.96
$22.69
52주 변동 폭
$8.02
$23.70
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
ELAN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.24 | 10.97B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
123.51 | 53.87B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.86 | 45.71B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.88 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.04 | 34.49B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
508.49 | 22.00B | 3.08B | 1.24B | 1.07B | 25.61 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
FDA conditionally approves Elanco’s treatment for screwworm in dogs By Investing.com - Investing.com Australia
FDA conditionally approves Elanco’s treatment for screwworm in dogs - Investing.com India
Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs - PR Newswire
Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around' - Benzinga
Elanco (ELAN): Valuation Check After Insider Buying Spree and New Restructuring Plan - Yahoo Finance
Elanco Animal Health Director Purchases 10,000 Shares - TradingView — Track All Markets
[Form 4] Elanco Animal Health Inc Insider Trading Activity - Stock Titan
Elanco Animal Health Inc (ELAN) EVP reports 66.4453 deferred stock units - Stock Titan
Elanco Animal Health Inc. (ELAN) CEO reports new deferred stock units award - Stock Titan
Elanco (ELAN) Stock Is Up, What You Need To Know - Finviz
Elanco Animal Health (NYSE:ELAN) Shares Little Changed After Results - Kalkine Media
Elanco Animal Health (NYSE:ELAN) Shares Gap Up Following Insider Buying Activity - MarketBeat
Smart Money Move: Jeffrey N Simmons Grabs $478K Worth Of Elanco Animal Health Stock - Benzinga
Robert M VanHimbergen Takes a Bullish Stance: Acquires $150K In Elanco Animal Health Stock - Benzinga
Are Medical Stocks Lagging Elanco Animal Health (ELAN) This Year? - Yahoo Finance
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm - GlobeNewswire Inc.
Elanco to Layoff 300 Employees, Shift Another 300 to Other Locations - 101.5 WKKG
Insider Purchases Boost Elanco (ELAN) Stock - GuruFocus
Elanco Animal Health EVP Modi buys $95,984 in stock By Investing.com - Investing.com South Africa
Elanco Animal Health EVP Modi buys $95,984 in stock - Investing.com
Insider Buying: Elanco Animal Health (NYSE:ELAN) CFO Purchases 6,950 Shares of Stock - MarketBeat
ELAN FinancialsIncome Statement - Quiver Quantitative
Elanco Animal Health EVP VanHimbergen buys $150k in stock - Investing.com
VP Modi Buys 4,500 ($96K) Of Elanco Animal Health Inc [ELAN] - TradingView — Track All Markets
Elanco (ELAN) EVP Rajeev Modi reports purchase of 4,500 shares - Stock Titan
Elanco Animal Health Inc (ELAN) CFO discloses purchase of 6,950 shares - Stock Titan
Elanco Animal Health (ELAN) CEO Jeffrey Simmons adds 22,000 shares - Stock Titan
The career advice Elanco's CEO shares with his six kids - Business Insider
All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy - Yahoo Finance
Analysts’ Top Healthcare Picks: Elanco Animal Health (ELAN), Mediwound (MDWD) - The Globe and Mail
Elanco Animal Health Incorporated $ELAN Holdings Cut by Frontier Capital Management Co. LLC - MarketBeat
Stifel Nicolaus Sticks to Their Buy Rating for Elanco Animal Health (ELAN) - The Globe and Mail
Animal Health Focused Elanco Details Pipeline Momentum, US Investments, Cost-Saving Plans - Benzinga
Elanco Animal Health Shifts Focus to U.S., Redefining Livestock R&D and Manufacturing - Bovine Veterinarian
Elanco Animal Health: Strategic Dual Channel Focus and Robust Innovation Pipeline Drive Buy Rating - TipRanks
Elanco Animal Health stock price target raised to $26 at Leerink Partners - Investing.com Canada
Elanco restructuring to affect 600 positions across the company - Feed Strategy
Stifel reiterates Buy rating on Elanco Animal Health stock, maintains $27 price target - Investing.com Canada
Elanco Animal Health (NYSE:ELAN) Rating Increased to Strong-Buy at Barclays - MarketBeat
First Trust Advisors LP Has $35.71 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
American Century Companies Inc. Increases Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Investor Day Defines New Era as Sustainable Growth Company - Finviz
Elanco Invests $400 Million in Indiana to Expand U.S. R&D and Manufacturing Operations - Southeast AgNET
How Protein And Pets Drove Elanco Animal Health's Double-Digit Gain In 2025 - Investor's Business Daily
Elanco Animal Health (NYSE:ELAN) Trading Down 4.5%Should You Sell? - MarketBeat
Elanco (ELAN) Announces Major Cost-Cutting Initiative - GuruFocus
Barclays Initiates Coverage on Elanco Animal Health (ELAN) with Overweight Rating | ELAN Stock News - GuruFocus
Elanco Animal Health Incorporated Announces Organizational Changes - marketscreener.com
Elanco Animal Health (NYSE:ELAN) Coverage Initiated by Analysts at Barclays - MarketBeat
Elanco Animal Health Incorporated Announces Continued Investment in Its U.S. Operations, Workforce and Communities over the Next Five Years - marketscreener.com
Elanco Animal Health Incorporated to Seek M&A - marketscreener.com
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.40%
자본화:
|
볼륨(24시간):